Bitcoin News Update: Prenetics’ Two-Pronged Approach Draws Cryptocurrency Companies and Celebrities in $48 Million Funding Round
- Prenetics raises $48M in oversubscribed offering with crypto firms, celebrities, and institutions. - Dual-warrant structure could unlock $216M, supporting IM8 supplements and Bitcoin treasury expansion. - IM8 achieves $100M ARR in 11 months; CEO targets $1B revenue and $1B Bitcoin holdings by 2029. - Strategic partners include Kraken, Bitdeer; aligns with rising institutional crypto adoption trends.
Prenetics Global Limited (NASDAQ: PRE) has raised $48 million through an equity offering that was oversubscribed, attracting a diverse group of investors, including major players from the cryptocurrency sector, institutional backers, and well-known celebrities. This fundraising round, which features a dual-warrant mechanism that could bring in an extra $216 million if fully exercised, highlights the health sciences firm's commitment to growing its IM8 supplement line and strengthening its
This $48 million capital raise comes on the heels of IM8’s swift rise in the global supplement market, reaching $100 million in annual recurring revenue just 11 months after its December 2024 debut. Co-founded with soccer legend David Beckham, IM8 now brings in over $8.6 million each month and forecasts sales between $160 million and $200 million for 2026. CEO Danny Yeung described IM8 as a key part of Prenetics’ “dual-engine strategy,” alongside its Bitcoin holdings, which have grown to 275 BTC (worth $31 million as of October 27) through a daily purchase program started in August, as noted in a
The equity offering includes Class A and B warrants, which can be exercised at 50% and 100% premiums over the $16.08 per-share price, giving investors the option to benefit from future stock gains. Strategic collaborators like Bitdeer Technologies Group (NASDAQ: BTDR) and XtalPi (2228.HK) contribute their expertise in Bitcoin mining and AI-powered health product innovation. Celebrity investors such as Sabalenka and Adrian Cheng, an early Prenetics backer, further reinforce the company’s consumer-focused direction.
Prenetics has also revealed intentions to sell off non-core businesses to focus its efforts on IM8 and expanding its Bitcoin portfolio. Yeung shared a five-year vision aiming for $1 billion in yearly revenue and $1 billion in Bitcoin assets, leveraging a robust financial position of $100 million in cash and $31 million in Bitcoin after the offering. This approach is in step with broader industry movements, such as record inflows into Bitcoin ETFs and increased institutional adoption of crypto treasuries, though it stands out amid recent fluctuations in Bitcoin options markets before Halloween expiries.
This fundraising round demonstrates rising institutional trust in business models that combine traditional and digital assets. Kraken’s involvement, following its own $500 million funding round led by Jane Street Capital, points to a growing trend of Wall Street firms expanding their crypto investments. At the same time, SpaceX’s recent $134 million Bitcoin wallet restructuring highlights the growing role of digital assets in corporate treasuries.
Prenetics’ Bitcoin reserves now place it among notable corporate holders, though it remains behind larger companies like Strategic (640,418 BTC) and MicroStrategy. By focusing on both consumer health and digital assets, Prenetics is positioning itself to benefit from the $704 billion global supplements industry and the increasing institutional embrace of Bitcoin.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Institutions Develop Blockchain Foundations, Signaling the Advancement of the Crypto Industry
- Institutional crypto adoption accelerates as venture funding, ETFs, and strategic acquisitions drive market maturation, per Cosmos Labs CEO Magnus Mareneck. - Coinbase's $375M Echo acquisition and BlackRock's $137.5M Ethereum/Bitcoin ETF inflows highlight infrastructure-building over speculation. - Cosmos emphasizes interoperability to support DeFi and tokenization, with partnerships enabling programmable banking and real-time settlements. - Mareneck warns of valuation risks (e.g., SEALSQ's 10.1x P/B rat

Solana News Update: Solana ETF Climbs While Token Declines: Institutional Demand Contrasts with Retail Outlook
- Bitwise's Solana Staking ETF (BSOL) raised $222.8M in assets on its 2025 debut, outpacing most new ETFs with $56M in first-day trading volume. - The fund offers direct Solana exposure with staking rewards, attracting institutional interest through a novel structure distinct from traditional spot ETFs. - SEC guidance on PoS and liquid staking enabled BSOL's launch, with Bitwise leveraging its European staking product experience to enter the U.S. market. - Despite BSOL's success, Solana's token price fell

Bitcoin Updates: The Crypto Market’s Psychological Maze Encounters AI’s Strategic Pathway Out
- Token Metrics AI Indices combat crypto volatility by using analytics to address psychological biases like FOMO and panic selling. - Bitcoin near $115,000 faces 2025-2026 price forecasts up to $500,000, driven by Fed rate cuts and U.S.-China cooperation boosting liquidity. - AI tools project $177,000–$427,000 BTC ranges based on market cap scenarios, while prioritizing risk mitigation through diversification and real-time monitoring. - Dynamic AI strategies balance growth and downside protection, using me

OceanPal’s Shift to AI and Blockchain Triggers 22.5% Drop in Share Price
- OceanPal Inc. pivoted to AI via a $120M investment in NEAR Protocol, launching SovereignAI to commercialize blockchain-based AI infrastructure. - The strategy targets 10% NEAR token ownership and leverages NVIDIA tech for confidential AI-cloud solutions, aligning with institutional interest in privacy-focused AI. - Despite continued shipping operations, OceanPal reported a $10.4M net loss and saw its stock drop 22.5% post-announcement, reflecting market skepticism about the strategic shift. - Backed by c
